Skip to main content
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2017 Nov 7;17:713. doi: 10.1186/s12879-017-2806-x

Correction to: The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study

Vera Golla 1, Kathryn Snow 2, Anna M Mandalakas 3, H Simon Schaaf 1, Karen Du Preez 1, Anneke C Hesseling 1,, James A Seddon 1,4,
PMCID: PMC5674833  PMID: 29115944

Correction

After publication of the original article [1] the authors noted that the following errors had occurred:

  • The name of the author H. Simon Schaaf had been incorrectly tagged as Simon H. Schaaf. This has been corrected in the author list above.

  • The first p value below Table 1 is listed as p < 0.011, however it should be p < 0.01. An updated version of this table is included with this Correction.

Table 1.

Baseline characteristics in children with household multidrug-resistant tuberculosis and drug-susceptible tuberculosis exposure

Risk factors and clinical states DS-TB exposure (n = 316) N (%) MDR-TB exposure (n = 229) N (%)
Child factors
 < 1 year 48 (15.2) 50 (21.8)
 1 year 66 (20.9) 41 (17.9)
 2 years 71 (22.5) 44 (19.2)
 3 years 73 (23.1) 56 (24.5)
 4 years 58 (18.4) 38 (16.6)
 Male 162 (51.3) 119 (52.2)
 Black African (vs. mixed race) 52 (16.5) 101 (44.1)**
 HIV-positive 1 (0.3) 8 (3.7)*
 BCG scar/vaccination documented 310 (98.1) 181 (81.2)**
 Previous tuberculosis treatment 8 (2.5) 21 (9.2)*
 Weight for age (z-score) < −2 32 (10.1) 23 (10.1)
 Sleeps in same room as TB source case 79 (25.3) 34 (15.0)**
 Sleeps in same bed as TB source case 20 (6.4) 57 (25.2)**
Adult source case /household factors
 Source case sputum acid-fast bacilli smear-positive 181 (62.9) 180 (80.0)**
 Household tobacco smoke exposure 245 (80.4) 145 (63.3)**
 Mean socioeconomic index (x/11), n (standard deviation) 4.0 (2.6) 4.1 (2.5)
Clinical states
 Exposure no infection 205 (65.7) 125 (61.3)
 Infection no disease 80 (25.6) 86 (38.1)*
 Disease 27 (8.7) 15 (6.6)

MDR-TB Mycobacterium tuberculosis resistant to rifampicin and isoniazid (defined by line probe assay)

DS-TB Mycobacterium tuberculosis susceptible to rifampicin and isoniazid (defined by line probe assay)

p < 0.01*; p < 0.001**

The original article has also been corrected.

Footnotes

Vera Golla and Kathryn Snow are Joint first authors.

Anneke C. Hesseling and James A. Seddon are Joint last authors.

The original article can be found online at https://doi.org/10.1186/s12879-017-2668-2.

Contributor Information

Anneke C. Hesseling, Email: annekeh@sun.ac.za

James A. Seddon, Email: james.seddon@imperial.ac.uk

Reference

  • 1.Golla V, Snow K, Mandalakas AM, Schaaf HS, Du Preez K, Hesseling AC, Seddon JA. The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study. BMC Infect Dis. 2017;17:593. doi:10.1186/s12879-017-2668-2. [DOI] [PMC free article] [PubMed]

Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES